12/06/2024
4:50 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
4:51 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
6:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:35 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:36 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:34 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/25/2024
3:42 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:20 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
3:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
3:31 PM | Verona Pharma (Subject)
| Form SC 13G | |
11/14/2024
8:47 AM | Deep Track Capital, LP (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/13/2024
7:46 PM | Verona Pharma (Subject)
VIVO VENTURES VII, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:57 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/07/2024
5:56 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:57 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:40 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:41 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
7:47 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
5:06 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:13 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:14 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:17 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:55 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:54 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:45 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:46 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:20 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:22 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:22 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
8:51 PM | Growth Equity Opportunities Fund IV, LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13D/A | |
08/12/2024
3:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:20 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
6:11 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:12 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:13 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:44 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
08/08/2024
7:51 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
8:28 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:29 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:30 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2024
8:43 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G | |
06/27/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:53 AM | Verona Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024
8:09 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:22 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:18 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:21 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:15 PM | Brady James Aloysius (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:16 PM | Cunningham Kenneth (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | SHAH MAHENDRA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Ullman Anders (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:18 PM | Sinha Vikas (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024
7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024
6:45 PM | Gupta Rishi (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024
8:40 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
7:15 PM | ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
8:00 AM | Verona Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
5:08 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
5:09 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
5:05 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/02/2024
5:07 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free VRNA Stock Alerts